Evidence map›Paper›PMID 31852314›Full record

SynthesisThe Journal of international medical research2020

The efficacy and safety of fluticasone propionate/formoterol compared with fluticasone propionate/salmeterol in treating pediatric asthma: a systematic review and meta-analysis.

Renzheng Guan, Yanli Liu, Dunqiang Ren, Jinfeng Li, Tao Xu, Haiyan Hu

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The Journal of international medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Renzheng GuanDepartment of Pediatrics, The Affiliated Hospital of Qingdao University, Qingdao, China.
Yanli LiuDepartment of Respiratory Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China.
Dunqiang RenDepartment of Respiratory Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China.
Jinfeng LiDepartment of Respiratory Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China.
Tao XuDepartment of Respiratory Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China.
Haiyan HuCenter of Diagnosis and Treatment of Breast Disease, The Affiliated Hospital of Qingdao University, Qingdao, China.
Affiliated Hospital of Qingdao University · CNQingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the efficacy and safety of fluticasone propionate/formoterol (FP/FORM) versus fluticasone propionate/salmeterol (FP/SAL) in treating pediatric asthma during a 12-week treatment cycle.

methodsRandomized controlled trials of FP/FORM compared with FP/SAL in treating pediatric asthma were searched systematically using Medline, Embase, and the Cochrane Controlled Trials Register.

resultsTwo articles including 546 patients were evaluated. The FP/SAL group showed obvious improvements in pre-dose forced expiratory volume in 1 s (FEV

conclusionCompared with FP/FORM, FP/SAL showed a clear improvement in pre-dose FEV

Indexed as

AsthmaPropionatesAndrostadienesBronchodilator AgentsChildDouble-Blind MethodDrug CombinationsFluticasoneFluticasone-Salmeterol Drug CombinationForced Expiratory VolumeFormoterol FumarateHumansTreatment OutcomeAndrostadienesBronchodilator AgentsDrug CombinationsFluticasoneFluticasone-Salmeterol Drug CombinationFormoterol FumaratePropionatesfluticasoneformoterolmeta-analysisPediatric asthmarandomized controlled trialsalmeterol

Identifiers

PMID31852314
PMCPMC7607222
OpenAlexW2996578451

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.